Login
Boehringer Ingelheim and Twist Bioscience Team Up for Therapeutic Antibody Discovery
Boehringer Ingelheim and Twist Bioscience will use Twist’s antibody libraries to discover therapeutic antibody candidates.
Twist Bioscience, a company that provides synthetic DNA libraries, announced a research collaboration with Boehringer Ingelheim on Sept. 9, 2021. The collaboration will allow Boehringer Ingelheim to use Twist’s antibody libraries to discover therapeutic antibodies for various targets.